Personalised vaccines will be tested on children with untreatable brain tumours as part of a world-first clinical trial ...
The four-year trial of about 70 children with "dismal prognoses" in eight hospitals across Australia will test the safety and ...
The study, co-led by The University of Queensland and the South Australian Health and Medical Research Institute (SAHMRI), in ...
Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay
Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay. •Newly created spin-off ...
Professor Brandon Wainwright of UQ's Frazer Institute is the trial's scientific lead.(Photo credit: The University of ...
SYDNEY, Feb. 3 (Xinhua) -- Australia has launched a world-first clinical trial using personalized mRNA vaccines to treat children and adolescents with advanced or treatment-resistant brain tumors.
A world-first trial in Australia will treat children with advanced brain cancer using technology from the COVID-19 jab.
Australia has launched the world’s first clinical trial testing personalized mRNA cancer vaccines in children suffering from ...
Doctors share what the findings may mean for the future of cancer treatment.
Vaccines that protect against infectious diseases like the flu or pneumonia are commonly made from a weakened form of the ...
New Scientist on MSN
Treating cancer before 3pm could help patients live longer
The most robust evidence to date shows that people with a type of lung cancer lived longer if they received immunotherapy before 3pm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results